Search Results 1211-1220 of 13928 for Assay
Patients with a positive HCV antibody at screening may be eligible if confirmatory testing (i.e., Recombinant Immunoblot Assay [RIBA], or HCV RNA viral load) ...
A global CDR® plus NACC FTLD score of 0 and an elevated level ofserum NfL as measured on the Simoa NF-Light Advantage Kit assay (pre-symptomatic participants); ...
... assays may be conducted. Patient must consent to provision of a sample of blood in order that the specific correlative marker assays may be conducted.
CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR) Rochester, MN. The purpose of this ...
... assay: Involved FLC level ≥5mg/dl (≥50mg/l) and an abnormal serum free light chain ratio (<0.26 or >1.65); Biopsy proven plasmacytoma (should be measured ...
The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...
Known history of serum or plasma progranulin level less than one standard deviation below the normal participant mean for the laboratory performing the assay.
... assay. Exclusion Criteria: Prior invasive malignancy (except node negative, non-melanomatous skin cancer) unless disease free for a minimum of 1095 days (3 ...
Likewise, the B cell assays under development will predict patients at risk of developing lung fibrosis and also identify patients that will benefit from B cell ...
Cell Potency Assay Score of 3, as determined by the Cell Analysis Core Lab results. Provide written informed consent. At screening, having the best ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.